New York Society of Addiction Medicine
April 12, 2019 by Daniel Schatz, MDKey Issues
The New York State Department of Health, the New York State Office of Alcoholism and Substance Abuse (OASAS), and the New York State Buprenorphine Working Group wrote a Best Practice document focused on misconceptions related to the use of buprenorphine for the treatment of opioid use disorder (OUD). NYSAM Board Member, Dr. Dan Schatz, wrote a summary of the document reviewing five misconceptions of buprenorphine treatment.
March 29, 2019 by Melissa Weimer, MDKey Issues
Melissa Weimer, Jeanette Tetrault, and J. Craig Allen recently published an op-ed in the New Haven Register highlighting the substance…
March 12, 2019 by Josh Lynch, DOKey Issues
People seeking treatment for opioid use disorder (OUD) should be able to access that care 24/7 and have choices of where they want to continue treatment. Places like Buffalo, NY are embracing this treatment ideal and changing the way patients access care for OUD.
February 15, 2019 by Melissa Weimer, MDKey Issues
Memo in Opposition Assembly bill 8566 /Senate bill 6815 Rules and regulations promoting recovery from opioid abuse and reducing diversion.…
January 15, 2019 by NYSAMKey Issues
On June 11, 2018, the New York State Senate introduced Bill 8987 to amend the public health law in relation…
July 3, 2018 by Melissa Weimer, MDKey Issues
WRGB CBS News aired a story with Dr. Melissa Weimer, chief of behavioral health and addiction medicine for St. Peter’s…